论文部分内容阅读
10月28日开始,由阿斯利康举办的我国首届CSCO靶向治疗知识竞赛在上海、北京、广州三个赛区正式拉开序幕,此次竞赛的目的在于将肿瘤靶向治疗这一先进的治疗方法更广泛和更正确地应用于肿瘤的的临床治疗中。
Starting from October 28, the first China CSCO targeted therapy knowledge contest held by AstraZeneca officially kicked off in three competition zones in Shanghai, Beijing and Guangzhou. The purpose of this competition is to target the cancer-targeted therapy to this advanced treatment The method is more widely and more correctly applied to the clinical treatment of tumors.